You have 9 free searches left this month | for more free features.

belzutifan

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

Recruiting
  • Renal Cell Carcinoma
  • Macquarie University, New South Wales, Australia
  • +1 more
Aug 15, 2022

Carcinoma, Renal Cell Trial in United States (Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Belzutifan
  • Boston, Massachusetts
  • +3 more
Jan 27, 2023

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • Belzutifan
  • (no location specified)
Sep 16, 2022

Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +16 more
Jun 2, 2023

VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)

Active, not recruiting
  • VHL - Von Hippel-Lindau Syndrome
  • +5 more
  • Belzutifan
  • Bethesda, Maryland
  • +10 more
Aug 16, 2022

Carcinoma, Hepatocellular, Colorectal Tumors, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Pembrolizumab, Belzutifan,

Recruiting
  • Carcinoma, Hepatocellular
  • +5 more
  • Duarte, California
  • +39 more
Jul 29, 2022

Healthy Trial in West Bend (Belzutifan)

Completed
  • Healthy
  • Belzutifan
  • West Bend, Wisconsin
    Spaulding Clinical
Nov 5, 2020

Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)

Recruiting
  • Pheochromocytoma/Paraganglioma
  • +2 more
  • Belzutifan
  • Los Angeles, California
  • +58 more
Jan 27, 2023

Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

Recruiting
  • Carcinoma, Renal Cell
  • Belzutifan
  • +2 more
  • Chandler, Arizona
  • +176 more
Jan 19, 2023

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Belzutifan
  • +2 more
  • Duarte, California
  • +250 more
Jan 27, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Birmingham, Alabama
  • +229 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023